Established Market Products

Established Market Portfolio

Topical drugs are an important part of therapy for dermatologic diseases. However, for a percentage of topical products, there are no generic drug equivalents available on the market. This can be because they require specialised manufacturing and complex clinical studies, which represent an important hurdle to accessing the market. Hyloris aims to help bridge this gap, giving patients and practitioners more choices when it comes to treatment products.

HY-EMP-016 topical gel is an antimiotic drug. This is a generic of an off-patent branded reference product currently sold in the U.S. pharmaceutical market without generic competition.

Fusidic acid cream is a topical antibiotic, often used to treat bacterial infections, including skin infections such as impetigo. This is a generic of an off-patent reference product currently sold in the Canadian pharmaceutical market without generic competition.

BACK TO ALL PRODUCTS

Any questions? Please contact us for all the answers you need!

If you have any enquiries about Hyloris, our mission, activities or any aspect of our company,
please click the link below to get in touch.

Contact Us